As a result, this protection was removed to increase the supply and ensure that the public has access to affordable drugs. ("Pharmaceutical Companies," n.d., pp. 97-99)
Some of the negative implications of this decision are that there could be large amounts of generic drugs produced. This is because the various protections were removed to the point, that a number of players could begin manufacturing the medication. Over the course of time, this could destroy any kind of financial incentive in these areas. Once this occurs, it means that any kind of profit motives for these firms to sell drugs in these areas will decrease. This is when the available supply could decline, because there is too much competition. ("Pharmaceutical Companies," n.d., pp. 97-99)

At the same time, the quality of products could be inferior. This is because many firms will have select procedures in place to ensure that everyone is receiving…...

mla

Bibliography

Global Report. (2009). UNAIDS. Retrieved from:  http://www.unaids.org/globalreport/documents/20101123_GlobalReport_full_en.pdf 

Pharmaceutical Companies. (n.d.)., 94 -- 103.

Hunter, S. (2003). Black Death. New York, NY: McMillian

Poku, N. (2005). AIDS in Africa. Cambridge: Poulty.

Paxil, Claritin vs. Allegra, etcetera.
However, all of that being allowed -- even if it did not add prohibitive costs, the packaging and marketing of drugs to consumers is absurd. A patient used to go to a doctor and ask for a doctor's expertise and advice in how to treat an ailment he or she was suffering. Now, patients see drugs advertised like cosmetics, and are encouraged to self-diagnose themselves as having a certain conditions, or to think that their condition is worse than it is, like a case of insomnia that might be better treated with less coffee during the day than a pill at night. Doctors are beset by patients demanding drugs, and drug reps pushing drugs, so is it any wonder than Americans are overmedicated, given that neither patients nor doctors are immune to advertising? The sad thing is that drugs cannot be ethically marketed like other…...

Pharmaceutical Companies and Physicians: A Discussion The power of pharmaceutical companies cannot and should not be underestimated in any manner. Their power is immense as is their influence and more consumers need to understand how they constantly shape the industries of health, medicine and wellness. However, it’s important to acknowledge the intensity of the connection between doctors and pharmaceutical companies. This is a connection that begins when doctors are in medical school—they are subjected to a barrage of gifts, meals, trinkets and drug samples that starts early and continues on throughout their professional careers (Kshirsagar &Vu, 2016). Clearly this rapport creates a conflict of interest that can be damaging to the healthcare system. In order to protect themselves, consumers and citizens everywhere should demand a greater level of transparency in regards to how doctors are being compensated among other things. This paper will discuss in depth the necessity for a higher level…...

Management
Case Analysis: Pharma, Intellectual Property

Prior to 2003, the U.S. pharmaceutical industry heavily restricted intellectual property rights that would allow African countries and others ravaged by AIDS to receive generic medicine

There are a great deal of shocking statistics regarding the global populations living with and dying from AIDS, particularly in the age group of 15 -- 19

Health is a factors that is considered relative to a country's wealth; in Africa, a continent that is rich in natural resources, yet those resources are not controlled by the indigenous peoples, the number of people with AIDS is yet another way that Africa's extreme poverty demonstrates itself

Most of the people in the world who died from AIDS annually, are those from the southern parts of Africa

Pharmaceutical treatments are not cheap or instantaneous; the industry booms and will continue to do so for years to come because of the nature of the treatments and economies

Intellectual…...

mla

References:

Shah, Anup. "Pharmaceutical Companies and AIDS." Global Issues: Social, Political, Economic and Environmental Issues That Affect Us All, Web, Available from:   2013 February 18.http://www.globalissues.org/article/53/pharmaceutical-corporations-and-aids .

UNAIDS. "2002 Report on the Global HIV / AIDS Epidemic." Provided.

Q1. Which factors have contributed most to the increase in drug expenditure? One notable healthcare trend in recent years has been the steady climb in drug expenditures. Improvements in technology and the aging of the population are two commonly-cited factors, as the population is living longer, has a higher rate of chronic health conditions such as heart disease and diabetes, and suffers multiple comorbid health conditions, pharmaceutical companies have risen to the challenge (and profited tremendously) from these concurrent developments. According to La Fleur, Fish, & Brixner (2008), during the years 1996-2000, “the average number of prescriptions per person also rose—from 7.3 to 10.4.1” (par. 5). But this alone cannot explain the increase, and there was also a significant increase (14%) in the amount of money pharmaceutical companies spent advertising to consumers, particularly older consumers (La Fleur, et al., 2008).
Prices for drugs have themselves increased, much more so in recent decades…...

mla

References

La Fleur, J., Fish, L, & Brixner, D. I. (2008). Trends in pharmaceutical expenditures: The impact on drug benefit design. American Health & Drug Benefits, 1(4), 29–34. Retrieved from:  

Why are prescription drug prices rising and how to they affect the US fiscal outlook? (2019). Peter G. Peterson Foundation. Retrieved from:  https://www.pgpf.org/blog/2019/11/why - are-prescription-drug-prices-rising-and-how-do-they-affect-the-us-fiscal-outlook

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106630/ 

New communication technologies require stricter scrutiny, as well. The threat of reprisal is the most effective measure against intellectual property right infringements, and for this reason one of the most essential actions that can be taken in this regard -- and frequently is -- is the filing of civil and criminal charges against companies that infringe upon these rights in an aggressive and uncompromising manner (Long 2000). This not only limits damages, but dissuades future infringement.
Protecting Other Firms

efraining from infringing on another company's tangible and intellectual property rights might be seem to be a simple task, but it does require that certain actions are taken by pharmaceutical company managers. First and foremost, knowledge of the property right laws in effect must be obtained and thoroughly understood in order to refrain from infringing upon them. With this knowledge in place, managers can ensure that any similarities that develop between their…...

mla

References

Ghauri, P. & Rao, P. (2008). "Intellectual property, pharmaceutical MNEs and the developing world." Accessed 17 January 2010.  http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6W5M-4SY6YJR-3&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_searchStrId=1171065541&_rerunOrigin=google&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=e667e8f8848aae7fd6fe1c222ed046d6 

GTN. (2004). "Intellectual property summary." Accessed 17 January 2010.  http://www.cid.harvard.edu/cidtrade/issues/ipr.html 

Kaufman, J. (2008). "Intellectual Property Rights and the Pharmaceutical Industry." Accessed 17 January 2010.  http://www.america.gov/st/econ-english/2008/April/20080429230451myleen0.4181027.html 

Long, C. (2000). "Intellectual property rights in emerging markets." Accessed 17 January 2010.  http://www.scribd.com/doc/2011460/Intellectual-Property-Rights-in-Emerging-Markets

Drug Development (From Nature to the Market)
The process of drug development is a complex one. The pharmaceutical industry is required to adhere to strict governmental regulations, set out by the Food and Drug Administration (FDA), which involve numerous phases of testing and clinical trials, close monitoring of the drug's effects on users, its stability, dosage forms (the preparation), and so on. This paper will describe the drug development process, as it proceeds from nature to the market.

Drugs that eventually make it to the marketplace can come from a variety of sources -- plants, animals, microbes, synthetic chemistry, biotechnology, and even modified molecules. Years of research and billions of dollars are invested by pharmaceutical companies as they seek out new, potential drugs for the market. All of this effort has resulted in the FDA's approval of 1,200 drugs for the marketplace since 1950 (Munos 960). The "recipes" that have gone…...

mla

Works Cited

Bamelis, Lotte; Evers, Silvia; Spinhoven, Philip; Arntz, Arnoud. "Results of a Multicenter Randomized Controlled Trial of the Clinical Effectiveness of Schema Therapy for Personality Disorders." The American Journal of Psychiatry, vol. 171, no. 3 (March 2014): 305-322.

Coustasse A, Kimble CA, Stanton RB, Naylor M. "Could the Pharmaceutical Industry

Benefit from Full-Scale Adoption of Radio-Frequency Identification (RFID) Technology with New Regulations?" Perspectives in Health Information Management (Fall, 2016).  http://perspectives.ahima.org/couldpharmabenefit/ 

Munos, Bernard. "Lessons from 60 Years of Pharmaceutical Innovation." Nature

Interest Group in HealthcareIn the article by Boggs (2006) on the role that Big Pharmathe pharmaceutical industryplays in serving as an interest group in healthcare, the author reviews several books on the subject and concludes that this interest group is exploiting modern American medicine, law, and capitalist systems to its advantage. It highlights for instance how the trade association PhMA is one of the largestinterestgroupsin Washington, DC, and how it uses its influence and money to lobby for regulations that would help rather than harm Big Pharma. It is a relationship that does not speak well of either the drug industry or the healthcare industry, as Boggs (2006) exposes a quid pro quo type of relationship in which profits are put before patients.Boggs (2006) explains that in the United States, the health care industry is a for-profit business. One way that profits are put before patients is in the form…...

mla

ReferencesBoggs, C. (2006). Review essay: Big Pharma and American medicine. New Political Science, 27(3), 407-421.Walters, J. (2018). Interview: \\\\\\\\\\\\\\\'I don’t know how they live with themselves\\\\\\\\\\\\\\\' – artist Nan Goldin? takes on the billionaire family behind OxyContin. Retrieved from  https://www.theguardian.com/artanddesign/2018/jan/22/nan-goldin-interview-us-opioid-epidemic-heroin-addict-oxycontin-sackler-family

Because of the importance that pharmaceuticals will play in the 21st century, getting a degree in this field can provide me with numerous career alternatives. In addition to preparing drugs and providing advice, pharmacists can educate physicians and other healthcare workers on the choice, amount, and side effects of medications. Pharmacists can also work in a host of different sites.

Increasingly, pharmacists are playing a role in nontraditional situations as well. Some are involved with research for pharmaceutical manufacturers, developing new medications and therapies and testing their effects on patients. Others take jobs in marketing or sales, offering numerous resources and expertise to clients on a medication's use, effectiveness, and possible concerns. Some pharmacists also are employed by health insurance companies, developing benefit packages and implementing cost-benefit analyses on specific medications. Others are working with the government, pharmaceutical professional associations, or universities as professors and researchers.

Regardless of what avenue I choose,…...

Doctors Drugs
Although the Affordable Health Care Act represents a step in the right direction towards encouraging all Americans to avail themselves of medical services, the bill fails to address the root causes of problems in the system. The American health care system is flawed because it is a for-profit model that places profits far ahead of patients. When profits come ahead of patients, the result is an inability to fulfill the ethical duties of being a health care worker. A progressive transformation of the American health care system would systematically undo the nefarious link between corporate interests and the interests of health care.

The relationship between doctors and drug companies has been well established and well documented. Major news media resources like The Atlantic, as well as professional peer-reviewed journals like the New England Journal of Medicine cover stories addressing the potential ethical conundrums inherent in a cozy connection between physicians…...

mla

References

Campbell, E.G. (2007). Doctors and drug companies -- Scrutinizing influential relationships. New England Journal of Medicine 2007;357: 1796-1797.

Carollo, K. (2010). Pay dirt: hundreds of doctors earned big money from drug companies. ABC News. 25 October, 2010. Retrieved online:  http://abcnews.go.com/Health/Wellness/drug-companies-payments-doctors-revealed-database/story?id=11929217 

"Let the Sunshine In," (2013). The Economist. Mar 2, 2013. Retrieved online:  http://www.economist.com/news/business/21572784-new-efforts-reveal-ties-between-doctors-and-drug-firms-let-sunshine 

Moynihan, R. (2003). Who pays for the pizza? BMJ 2003; 326:1189.

Saudi Arabian pharmaceutical market is one of the largest in the Middle East. Within the Gulf Cooperation Council (GCC), Saudi Arabia represents 65%, or $1.7 billion, of the pharmaceutical market (EPSICOM, 2011). This work will analyze the unique opportunities within the Saudi pharmaceutical industry along with challenges, such as heavily regulated price controls and the barriers to access faced by international pharmaceutical companies. Through a better understanding of these factors, a more complete picture of the market can be obtained.
Saudi Arabia is a unique pharmaceutical market. It is the largest consumer in the GCC, with more than 82% of the medicines utilized being imported (aines, 2009). Also, the GCC is unique from nearly every other global region in that patients favor brand products over generics. This is despite that generics are the vast majority of the drugs produced in the Kingdom and the GCC. One study estimates the market…...

mla

Bains, E. (2009). Pharmaceuticals: Bringing in the Global Leaders. Middle East Econ. Dig. 53(33).

EPSICOM. (2011). The Pharmaceutical Market: Saudi Arabia. Last Modified 31 Oct 2011. URL: Http://www.espicom.com/prodcat2.nsf/Product_ID_Lookup/00000367?

OpenDocument

European pharmaceutical dispensing customs and laws are significantly different than in the U.S. In Germany, for example, one cannot buy vitamins (above a certain small dosage) or aspirin anywhere but a pharmacy. Most drugs we consider OTC are still limited to the pharmacy in many European countries.

In considering whether to push for DTC advertising in Europe, American pharmaceutical companies will have to tread carefully, and be mindful of the special political clout carried by pharmacies and physicians.

Culture' and the limits of innovation in marketing: Ernest Dichter, motivation studies and psychoanalytic consumer research in Great ritain, 1950s -- 1970s (Schwarzkopf, 2007)

This study from the University of London talks about the attempt of American companies and advertising agencies to bring the results of psychoanalysis to Great ritain in the 1950's to the 1970's, and the difficulties encountered. America pioneered in consumer motivational research, which was popularized by Vance Packard in "The Hidden…...

mla

Bibliography

Economist. (2007, April 26). Counter-attacking the Kremlin. Economist, p. n.p.

Guthrie, P. (2007). Direct-to-consumer advertising debated. CMAJ, n.p.

Pfanner, E. (2007, March 22). Marketers Have Eyes on the 'Third Screen'. New York Times, p. n.p.

Schwarzkopf, S. (2007). 'Culture' and the limits of innovation in marketing: Ernest Dichter, motivation studies and psychoanalytic consumer research in Great Britain, 1950s -- 1970s. Management and Organisational History, 219-236.

Strategic Analysis of Johnson & Johnson Pharmaceutical Division
This study provides the strategic analysis of Johnson & Johnson's pharmaceutical division to assist the company developing an effective strategy to achieve the competitive market advantages. The paper uses the SWOT analysis, PEST analysis and Porter's five forces for the strategic analysis. The outcomes of the analysis reveal that Johnson & Johnson is one of the top players in the pharmaceutical industry making the company enjoying superior market advantages in the United States and outside the United States. However, the company is still facing stiff competitions with other key players in the industry. Moreover, the company has not been able to reduce its cost of operations. The study recommends that Johnson & Johnson should launch its products in China to enjoy huge Chinese markets. Moreover, the company should take advantage of Chinese low stringent laws and regulations to produce drugs for Indian and…...

mla

Reference

Arnum, P.V. (2015). Outlook 2018: The Current and Future Direction of the Pharma Industry. IMS Market Prognosis.

Gates, L.P. (2010). Strategic Planning with Critical Success Factors and Future Scenarios: An Integrated Strategic Planning Framework. Technical Report. Carnegie Mellon University. Software Engineering Institute.

KPMG (2011). Future Pharma Five Strategies to Accelerate the Transformation of the Pharmaceutical Industry by 2020. KPMG LLP, UK.

Phrama (2016). 2016 Profile Biopharmaceutical Research Industry. Washington, DC: PhRMA.

Wyeth may have been prescient in recognizing the need to break the mold in pharmaceutical research: the old model of heavy, expensive and long research projects (with a concomitant high rate of failure) needed to be addressed. Also, the earlier emphasis on the industry in finding the "next blockbuster" is now giving way to the new realities of smaller niches, more specialized products, and shorter product development cycles.
Appendix

Wyeth Rated est in Pharmaceutical Industry on the Wall Street Journal Patent Scorecard

Madison, N.J., August 9, 2007 - Wyeth (NYSE: WYE) announced today that the August 7, 2007 issue of the Wall Street Journal® Patent Scorecard ™ ranks Wyeth first among 35 global pharmaceutical companies evaluated for patent-based intellectual property, as measured by indicators including patents granted; quality of patents; Science Strength™, or the degree to which a company's patent portfolio is linked to core science; Research Intensity™, a comparative measure of…...

mla

Bibliography

Cremieux, P-Y, Meilleur, M-C.,Ouellette, P., Petit, SP, Zelder, M and Potvin, K. "Public and private pharmaceutical spending as determinants of health outcomes in Canada." Health Economics (2004): 107-116.

Epsicom. Wyeth: Performance, Products, Pipeline and Potential. Investor. New York: Epsicom Healthcare Intelligence, 2007.

FDA. "Humanitarian Use Exemption." 2007. FDA. 21 October 2007  http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfHDE/HDEInformation.cfm .

Feick, K. "Pharmaceutical Industry Faces Multiple Challenges - Future lies in Drug Pipeline Sustainability." Medical News Today 26 May 2005: n.p.

This was not the main finding, however. The study's focus was determining when generic pharmaceutical companies were likely to branch out into new markets via the manufacture of new drugs. The answer tended to be that companies entered markets with similar supply and demand levels as those of drugs already produced by the generic manufacturer. The study also interprets these results to mean that specialization based on supply capabilities is beneficial to all generic pharmaceutical manufacturing companies as it reduces the "overentering" (or over-saturation) of a market.
This was the bulk of what I learned from the article. Some of the other findings followed basic common sense -- markets with higher revenues, drugs that were purchased by hospitals more, and drugs that treated chronic conditions all received more market entries. This makes sense as these markets will increase the manufacturer's profits. I also learned -- though I should not have…...

For a research paper on the significance of the pharmaceutical industry and the business aspects of that, you could consider: * Strategic management of the pharmaceutical companies. * The overall business model for pharmaceutical companies. * Problems that are facing the business aspect of the industry. * How changing laws are affecting the pharmaceutical business. There are others, of course, and you can also narrow down one of the options here to provide something more specific. Maybe pick a particular pharmaceutical company and do an analysis on how the health care law may affect it? Finding a topic that's narrow enough is key, so....

Outline for an Essay on the Opioid Epidemic

I. Introduction

a. Overview of the opioid epidemic.

b. Brief history and how it evolved into a crisis.

II. The Scale of the Epidemic (500 words)

a. Statistics on opioid addiction, overdoses, and deaths.

b. The impact on various demographics and regions.

III. Causes of the Opioid Epidemic (600 words)

a. Over-prescription of painkillers and pharmaceutical companies' roles.

b. Economic factors and healthcare system issues.

c. Social and psychological factors contributing to addiction.

IV. Effects of the Opioid Epidemic (600 words)

a. On individuals (health, psychological impact, and....

1. The root causes of the opioid epidemic and how society can address them
2. The impact of opioid addiction on individuals, families, and communities
3. The role of pharmaceutical companies in fueling the opioid epidemic
4. The connection between mental health and opioid addiction
5. Strategies for preventing opioid addiction and promoting safe pain management
6. The criminal justice system's response to the opioid epidemic
7. The stigma surrounding opioid addiction and its impact on individuals seeking help
8. The economic costs of the opioid epidemic on healthcare systems and society
9. The role of healthcare providers in addressing the opioid epidemic
10. The potential for harm reduction....

Topic 1: The Root Causes of the Opioid Epidemic

Examine the complex interplay of factors contributing to the opioid epidemic, including the role of prescription practices, socioeconomic inequality, and the influence of pharmaceutical companies.

Topic 2: The Socioeconomic Impact of the Opioid Epidemic

Analyze the devastating consequences of the opioid epidemic on communities, including increased crime rates, poverty, and the strain on social services.

Topic 3: The Role of Prescription Practices in Fueling the Epidemic

Investigate the role of doctors, pharmacists, and the healthcare system in the overprescription of opioids and its impact on the epidemic.

Topic 4: The Failure of Law Enforcement....